关于如何减少阳性急性损伤的十个建议
Hendrik Booke1, Thilo von Groote1, Alexander Zarbock1
1Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
Clinical kidney journal
|February 14, 2025
概括
本综述提供了10个实用技巧,用于管理和预防住院患者的阳性急性损伤 (AKI). 早期识别易受伤害的患者和使用新的生物标志物可以改善结果并减少AKI的发生率.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 内部医学 内部医学
- 关键护理医学 关键护理医学
背景情况:
- 急性损伤 (AKI) 是住院患者常见且严重的疾病,通常是由医疗治疗和手术引起的.
- 阳性AKI的发病率很大,导致临床结果更差,发病率增加.
研究的目的:
- 提供关于管理和预防阳性AKI的实际指导.
- 强调早期检测,新生物标志物和预防策略的重要性.
- 讨论AKI的长期影响及其向慢性病的进展.
主要方法:
- 审查与AKI管理相关的当前文献和临床实践.
- 使用流行病学数据识别脆弱患者群体.
- 讨论诊断标准,压力和损伤生物标志物以及预防措施.
- 关于脏替代疗法和管理AKI进展的指导.
主要成果:
- 提出了十个实用技巧,用于管理和避免阳性AKI.
- 建议使用流行病学数据和脏应激生物标志物来查高风险患者.
- 倡导改善血液动力学,避免毒药物,并实施新的损伤生物标志物.
- 讨论严重AKI的管理,包括脏替代疗法和furosemide压力测试实用性.
- 强调长期监测AKI后的功能,以管理慢性病的进展.
结论:
- 积极的管理和预防策略对于减少阳性AKI至关重要.
- 新型生物标志物和改进的诊断方法可以提高早期检测和患者护理.
- 长期监测对于减轻AKI的后果和预防慢性病进展至关重要.
相关概念视频
01:11Renal Failure: Dose Adjustments
60
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
60
01:17Factors Affecting Renal Clearance: Renal Impairment
48
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
48
01:25Antihypertensive Drugs: Direct Renin Inhibitors
474
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
474
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
371
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
371
01:28Renal Drug Excretion: Tubular Secretion
105
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
105
01:14Prevention of Further Absorption of Poison
777
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
777